MDM2 and MDMX can interact differently with ARF and members of the p53 family

被引:73
作者
Wang, XQ
Arooz, T
Siu, WY
Chiu, CHS
Lau, A
Yamashita, K
Poon, RYC
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Life Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
ARF; MDM2; MDMX; p53; p63; p73; tumor suppressor;
D O I
10.1016/S0014-5793(01)02124-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the p53 family of transcription factors have essential roles in tumor suppression and in development, MDM2 is an essential regulator of p53 that can inhibit the transcriptional activity of p53, shuttle p53 out of the nucleus, and target p53 for ubiquitination-mediated degradation. Little is known about the interaction and selectivity of different members of the p53 family (p53, p63, and p73) and the MDM2 family (MDM2 and MDMX). Here we show that the transcriptional activities of p53 and p73, but not that of p63, were inhibited by both MDM2 and MDMX. Consistent with these, we found that MDMX can physically interact with p53 and p73, but not with p63, Moreover, ectopically expressed MDM2 and MDMX could induce alterations in the subcellular localization of p73, but did not affect the subcellular localization of p53 and p63. Finally, we demonstrate that while ARF can interact with MDM2 and inhibit the regulation of p53 by MDM2. no interaction was found between ARF and MDMX. These data reveal that significant differences and selectivity exist between the regulation of different members of the p53 family by MDM2 and MDMX. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 54 条
  • [1] Agami R, 1999, NATURE, V399, P809
  • [2] Mdm2 binds p73α without targeting degradation
    Bálint, E
    Bates, S
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (27) : 3923 - 3929
  • [3] Enhanced phosphorylation of p53 by ATN in response to DNA damage
    Banin, S
    Moyal, L
    Shieh, SY
    Taya, Y
    Anderson, CW
    Chessa, L
    Smorodinsky, NI
    Prives, C
    Reiss, Y
    Shiloh, Y
    Ziv, Y
    [J]. SCIENCE, 1998, 281 (5383) : 1674 - 1677
  • [4] Comparative study of the p53-mdm2 and p53-MDMX interfaces
    Böttger, V
    Böttger, A
    Garcia-Echeverria, C
    Ramos, YFM
    van der Eb, AJ
    Jochemsen, AG
    Lane, DP
    [J]. ONCOGENE, 1999, 18 (01) : 189 - 199
  • [5] Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
    Canman, CE
    Lim, DS
    Cimprich, KA
    Taya, Y
    Tamai, K
    Sakaguchi, K
    Appella, E
    Kastan, MB
    Siliciano, JD
    [J]. SCIENCE, 1998, 281 (5383) : 1677 - 1679
  • [6] Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome
    Celli, J
    Duijf, P
    Hamel, BCJ
    Bamshad, M
    Kramer, B
    Smits, APT
    Newbury-Ecob, R
    Hennekam, RCM
    Van Buggenhout, G
    van Haeringen, B
    Woods, CG
    van Essen, AJ
    de Waal, R
    Vriend, G
    Haber, DA
    Yang, A
    McKeon, F
    Brunner, HG
    van Bokhoven, H
    [J]. CELL, 1999, 99 (02) : 143 - 153
  • [7] Two new p73 splice variants, γ and δ, with different transcriptional activity
    De Laurenzi, V
    Costanzo, A
    Barcaroli, D
    Terrinoni, A
    Falco, M
    Annicchiarico-Petruzzeli, M
    Levrero, M
    Melino, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) : 1763 - 1768
  • [8] Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
    Dobbelstein, M
    Wienzek, S
    König, C
    Roth, J
    [J]. ONCOGENE, 1999, 18 (12) : 2101 - 2106
  • [9] Comparative analysis of p73 and p53 regulation and effector functions
    Fang, L
    Lee, SW
    Aaronson, SA
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 147 (04) : 823 - 830
  • [10] Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6
    Freedman, DA
    Levine, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7288 - 7293